flow trial glp 1 glp-1 receptor agonist kidney outcomes semaglutide 2024 results Long-term kidney outcomes of Semaglutides Are Poised to Remake

There are many papers which demonstrate that homocysteine around 6 or 7 is quite healthy for lowering cardiovascular risk

Sleep and recovery Sleep deprivation undermines weight loss through multiple mechanisms

Susceptibility to multiple sclerosis: interplay between genes and environment

(2025) investigated whether coronary computed tomography angiography (CCTA) can identify obese or overweight, nondiabetic individuals at cardiovascular risk levels comparable to those enrolled in the SELECT trial, which showed a 20 % reduction in major adverse cardiovascular events (MACE) with semaglutide

Mediators Inflammation (2019) 2019:2923072